I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Casasnovas, O.
155
results:
Search for persons
X
Format
Online (155)
Mediatypes
Articles (Online) (80)
OpenAccess-fulltext (75)
Languages
english (129)
more...
french (14)
spanish (3)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC n..:
Dufour, J.
;
Choquet, S.
;
Hoang-Xuan, K.
...
Annals of Hematology. 102 (2023) 5 - p. 1159-1169 , 2023
Link:
https://doi.org/10.1007/..
?
2
Transfusion needs after CD19 CAR T‐cells for large B‐cell l..:
Vic, S.
;
Thibert, J.
;
Bachy, E.
...
Hematological Oncology. 41 (2023) S2 - p. 534-536 , 2023
Link:
https://doi.org/10.1002/..
?
3
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG ..:
Sarkozy, C.
;
Thieblemont, C.
;
Oberic, L.
...
Hematological Oncology. 41 (2023) S2 - p. 151-152 , 2023
Link:
https://doi.org/10.1002/..
?
4
Distinct molecular determinants of treatment‐failure in eld..:
Rossi, C.
;
Boegeholz, J. L.
;
Alig, S. K.
...
Hematological Oncology. 41 (2023) S2 - p. 321-322 , 2023
Link:
https://doi.org/10.1002/..
?
5
Cell‐free DNA sequencing allows the identification of the m..:
Sako, N.
;
Delfau, M.
;
Bachy, E.
...
Hematological Oncology. 41 (2023) S2 - p. 338-339 , 2023
Link:
https://doi.org/10.1002/..
?
6
RISK STRATIFICATION OF DLBCL WITH MVED2 SCORE USING INTEGRA..:
Thieblemont, C.
;
Chartier, L.
;
Vercellino, L.
...
Hematological Oncology. 41 (2023) S2 - p. 91-91 , 2023
Link:
https://doi.org/10.1002/..
?
7
Prognostic Value of Lymphopenia and Total Metabolic Tumor V..:
Willaume, A.
;
Chartier, L.
;
Ricci, R.
...
Hematological Oncology. 41 (2023) S2 - p. 346-347 , 2023
Link:
https://doi.org/10.1002/..
?
8
CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HE..:
Loyaux, R.
;
Sako, N.
;
Quang, V. Tran
...
Hematological Oncology. 41 (2023) S2 - p. 108-110 , 2023
Link:
https://doi.org/10.1002/..
?
9
RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE I..:
Thieblemont, C.
;
Lamy, T.
;
Tani, M.
...
Hematological Oncology. 41 (2023) S2 - p. 104-106 , 2023
Link:
https://doi.org/10.1002/..
?
10
Long term follow‐up of untreated/relapsing MCL patients wit..:
Le Gouill, S.
;
Morschhauser, F.
;
Chiron, D.
...
Hematological Oncology. 41 (2023) S2 - p. 478-479 , 2023
Link:
https://doi.org/10.1002/..
?
11
AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐..:
Houot, R.
;
Bachy, E.
;
Cartron, G.
...
Hematological Oncology. 41 (2023) S2 - p. 147-148 , 2023
Link:
https://doi.org/10.1002/..
?
12
P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT ..:
Cartron, G.
;
Bachy, E.
;
Tilly, H.
...
HemaSphere. 6 (2022) - p. 1023-1024 , 2022
Link:
https://doi.org/10.1097/..
?
13
P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NER..:
Renaud, L.
;
Stéphan, P.
;
durand, S.
...
HemaSphere. 6 (2022) - p. 1103-1104 , 2022
Link:
https://doi.org/10.1097/..
?
14
ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACT..:
Wang, M.
;
Rule, S.
;
Zinzani, P. L.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
15
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLI..:
Camus, V.
;
Belot, Aurél.
;
Oberic, L.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
1-15